News

UK: GlaxoSmithKline silent on talk of private equity swoop for Lucozade, Ribena

Most popular

Stoli Group’s AC/DC Thunderstruck Tequila- Comment

As Irish whiskey comes of age, so do its problems

Why water has become more important than wine

Interview - Mark Sandys, Diageo's head of beer

MORE

GlaxoSmithKline (GSK) has declined to comment on a report a US private equity firm is readying a bid for its Lucozade and Ribena brands.


Related Content

Was Brown-Forman ever on the cards? The future of M&A for Constellation Brands - Analysis

Was Brown-Forman ever on the cards? The future of M&A for Constellation Brands - Analysis...

CHAMP finds a suitor for Accolade Wines as Carlyle talks come good

CHAMP finds a suitor for Accolade Wines as Carlyle talks come good...

This week in soft drinks & bottled water, featuring the vegan opportunity, Coca-Cola Co's Canadian asset sale and Lucozade comes out boxing

This week in soft drinks & bottled water, featuring the vegan opportunity, Coca-Cola Co's Canadian a...

Private equity most likely SABMiller Central & Eastern Europe buyer – analyst

Private equity most likely SABMiller Central & Eastern Europe buyer – analyst...

Oops! This article is copy protected.

Why can’t I copy the text on this page?

The ability to copy articles is specially reserved for people who are part of a group membership.

How do I become a group member?

To find out how you and your team can copy and share articles and save money as part of a group membership call Sean Clinton on
+44 (0)1527 573 736 or complete this form..



Forgot your password?